Gurbatri, C. R., Arpaia, N., & Danino, T. (2022). Engineering bacteria as interactive cancer therapies. Science, 378(6622), 858–864. https://doi.org/10.1126/science.add9667

Cohen, A. O., Woo, S.-H., Zhang, J., Cho, J., Ruiz, M. E., Gong, J., Du, R., Yarygina, O., Jafri, D. Z., Bachelor, M. A., Finlayson, M. O., Soni, R. K., Hayden, M. S., & Owens, D. M. (2022). Tbc1d10c is a selective, constitutive suppressor of the CD8 T-cell anti-tumor response. OncoImmunology, 11(1). https://doi.org/10.1080/2162402x.2022.2141011

Jibb, L. A., Nanos, S. M., Alexander, S., Malfitano, C., Rydall, A., Gupta, S., Schimmer, A. D., Zimmermann, C., Hales, S., Nissim, R., Marmar, C., Schultebraucks, K., Mah, K., & Rodin, G. (2022). Traumatic stress symptoms in family caregivers of patients with acute leukaemia: protocol for a multisite mixed methods, longitudinal, observational study. BMJ Open, 12(11), e065422. https://doi.org/10.1136/bmjopen-2022-065422

Li, T., Akinade, T., Zhou, J., Wang, H., Tong, Q., He, S., Rinebold, E., Valencia Salazar, L. E., Bhansali, D., Zhong, Y., Ruan, J., Du, J., Dalerba, P., & Leong, K. W. (2022). Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis. Advanced Science, 9(33). Portico. https://doi.org/10.1002/advs.202203949

Aziz‐Bose, R., Zheng, D. J., Umaretiya, P. J., Ilcisin, L., Stevenson, K., Koch, V., Valenzuela, A., Cole, P. D., Gennarini, L. M., Kahn, J. M., Kelly, K. M., Tran, T., Michon, B., Welch, J. J. G., Silverman, L. B., Wolfe, J., & Bona, K. (2022). Feasibility of oncology clinical trial‐embedded evaluation of social determinants of health. Pediatric Blood & Cancer, 69(11). Portico. https://doi.org/10.1002/pbc.29933

Doyle-Lindrud, S. (2022). Personalized cancer care. Journal of the American Association of Nurse Practitioners, 34(11), 1184–1186. https://doi.org/10.1097/jxx.0000000000000793

Doshi, S. D., Lichtenstein, M. R. L., Beauchemin, M. P., Raghunathan, R., Lee, S., Law, C., Accordino, M. K., Elkin, E. B., Wright, J. D., & Hershman, D. L. (2022). Factors Associated With Patients Not Receiving Oral Anticancer Drugs. JAMA Network Open, 5(10), e2236380. https://doi.org/10.1001/jamanetworkopen.2022.36380

Kestenbaum, A., McEniry, K. A., Friedman, S., Kent, J., Ma, J. D., & Roeland, E. J. (2021). Spiritual AIM: assessment and documentation of spiritual needs in patients with cancer. Journal of Health Care Chaplaincy, 28(4), 566–577. https://doi.org/10.1080/08854726.2021.2008170

Ramsey, S. D., Bansal, A., Sullivan, S. D., Lyman, G. H., Barlow, W. E., Arnold, K. B., Watabayashi, K., Bell-Brown, A., Kreizenbeck, K., Le-Lindqwister, N. A., Dul, C. L., Brown-Glaberman, U. A., Behrens, R. J., Vogel, V., Alluri, N., & Hershman, D. L. (2022). Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing. JAMA Network Open, 5(10), e2238191. https://doi.org/10.1001/jamanetworkopen.2022.38191

Tavaré, R., Danton, M., Giurleo, J. T., Makonnen, S., Hickey, C., Arnold, T. C., Kelly, M. P., Fredriksson, F., Bruestle, K., Hermann, A., Ullman, E., Edelmann, K. H., Potocky, T., Dudgeon, D., Bhatt, N. B., Doubrovin, M., Barry, T., Kyratsous, C. A., Gurer, C., … Kirshner, J. R. (2022). Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054. Cancer Immunology Research, 10(10), 1190–1209. https://doi.org/10.1158/2326-6066.cir-21-0405

Nobre, A. R., Dalla, E., Yang, J., Huang, X., Wullkopf, L., Risson, E., Razghandi, P., Anton, M. L., Zheng, W., Seoane, J. A., Curtis, C., Kenigsberg, E., Wang, J., & Aguirre-Ghiso, J. A. (2022). ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung. Nature Cancer, 3(10), 1165–1180. https://doi.org/10.1038/s43018-022-00424-8

Liu, Y., & Gu, W. (2022). The complexity of p53-mediated metabolic regulation in tumor suppression. Seminars in Cancer Biology, 85, 4–32. https://doi.org/10.1016/j.semcancer.2021.03.010

Austin, J. D., Burke, K., Argov, E. J. L., Hillyer, G. C., Schmitt, K. M., McDonald, J., Shelton, R. C., Terry, M. B., & Tehranifar, P. (2022). Experience of a National Cancer Institute-Designated Community Outreach and Engagement Program in Supporting Communities During the COVID-19 Pandemic. Journal of Community Health, 47(5), 862–870. https://doi.org/10.1007/s10900-022-01115-2

Bledsoe, A. C., Garber, J. J., Ye, W., Roelstraete, B., Murray, J. A., & Ludvigsson, J. F. (2022). Mortality and cancer in eosinophilic gastrointestinal disorders distal to the esophagus: nationwide cohort study 1990–2017. Journal of Gastroenterology, 57(10), 735–747. https://doi.org/10.1007/s00535-022-01904-5

Konig, S., Strobel, H., Grunert, M., Lyszkiewicz, M., Brühl, O., Karpel-Massler, G., Ziętara, N., La Ferla-Brühl, K., Siegelin, M. D., Debatin, K.-M., & Westhoff, M.-A. (2022). Unblinding the watchmaker: cancer treatment and drug design in the face of evolutionary pressure. Expert Opinion on Drug Discovery, 17(10), 1081–1094. https://doi.org/10.1080/17460441.2022.2114454

Hamid, O., Chiappori, A. A., Thompson, J. A., Doi, T., Hu-Lieskovan, S., Eskens, F. A. L. M., Ros, W., Diab, A., Spano, J.-P., Rizvi, N. A., Wasser, J. S., Angevin, E., Ott, P. A., Forgie, A., Yang, W., Guo, C., Chou, J., & El-Khoueiry, A. B. (2022). First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer, 10(10), e005471. https://doi.org/10.1136/jitc-2022-005471

Bauer, T., Cho, B. C., Heist, R., Bazhenova, L., Werner, T., Goel, S., Kim, D.-W., Adkins, D., Carvajal, R. D., Alva, A., Eaton, K., Wang, J., Liu, Y., Yan, X., Christensen, J., Neuteboom, S., Chao, R., & Pant, S. (2022). First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors. Investigational New Drugs, 40(5), 990–1000. https://doi.org/10.1007/s10637-022-01274-y

Tomlinson, D., Robinson, P. D., Gibson, P., Beauchemin, M., Grimes, A., Dadzie, G., Mairs, M., Plenert, E., Vettese, E., Cox, S., Dupuis, L. L., & Sung, L. (2022). Creating and adapting an infection management care pathway in pediatric oncology. Supportive Care in Cancer, 30(10), 7923–7934. https://doi.org/10.1007/s00520-022-07216-x

Tergas, A. I., Prigerson, H. G., Shen, M. J., Dinicu, A. I., Neugut, A. I., Wright, J. D., Hershman, D. L., & Maciejewski, P. K. (2022). Association between immigrant status and advanced cancer patients’ location and quality of death. Cancer, 128(18), 3352–3359. Portico. https://doi.org/10.1002/cncr.34385

Cogan, J. C., Accordino, M. K., Beauchemin, M. P., Spivack, J. H., Ulene, S. R., Elkin, E. B., Melamed, A., Taback, B., Wright, J. D., & Hershman, D. L. (2022). Efficacy of a password‐protected, pill‐dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery. Cancer, 128(18), 3392–3399. Portico. https://doi.org/10.1002/cncr.34384

Rosenquist, R., Cuppen, E., Buettner, R., Caldas, C., Dreau, H., Elemento, O., Frederix, G., Grimmond, S., Haferlach, T., Jobanputra, V., Meggendorfer, M., Mullighan, C. G., Wordsworth, S., & Schuh, A. (2022). Clinical utility of whole-genome sequencing in precision oncology. Seminars in Cancer Biology, 84, 32–39. https://doi.org/10.1016/j.semcancer.2021.06.018

Isaacson, M. J., Duran, T., Johnson, G., Soltoff, A., Jackson, S., Petereit, D., Armstrong, K., & Daubman, B.-R. (2022). “Calling the Spirit Back:” Spiritual Needs Among Great Plains American Indians. Journal of Pain and Symptom Management, 64(3), 268–275. https://doi.org/10.1016/j.jpainsymman.2022.05.014

Gindin, T., & Hsiao, S. J. (2022). Analytical Principles of Cancer Next Generation Sequencing. Clinics in Laboratory Medicine, 42(3), 395–408. https://doi.org/10.1016/j.cll.2022.04.003

van der Zee, E. N., Termorshuizen, F., Benoit, D. D., de Keizer, N. F., Bakker, J., Kompanje, E. J. O., Rietdijk, W. J. R., & Epker, J. L. (2021). One-year Mortality of Cancer Patients with an Unplanned ICU Admission: A Cohort Analysis Between 2008 and 2017 in the Netherlands. Journal of Intensive Care Medicine, 37(9), 1165–1173. https://doi.org/10.1177/08850666211054369

Jobanputra, V., Wrzeszczynski, K. O., Buttner, R., Caldas, C., Cuppen, E., Grimmond, S., Haferlach, T., Mullighan, C., Schuh, A., & Elemento, O. (2022). Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology. Seminars in Cancer Biology, 84, 23–31. https://doi.org/10.1016/j.semcancer.2021.07.003

Navi, B. B., Zhang, C., Sherman, C. P., Genova, R., LeMoss, N. M., Kamel, H., Tagawa, S. T., Saxena, A., Ocean, A. J., Kasner, S. E., Cushman, M., Elkind, M. S. V., Peerschke, E., & DeAngelis, L. M. (2022). Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes. Journal of Thrombosis and Haemostasis, 20(9), 2046–2057. https://doi.org/10.1111/jth.15779

Dercle, L., McGale, J., Sun, S., Marabelle, A., Yeh, R., Deutsch, E., Mokrane, F.-Z., Farwell, M., Ammari, S., Schoder, H., Zhao, B., & Schwartz, L. H. (2022). Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy. Journal for ImmunoTherapy of Cancer, 10(9), e005292. https://doi.org/10.1136/jitc-2022-005292

Meggendorfer, M., Jobanputra, V., Wrzeszczynski, K. O., Roepman, P., de Bruijn, E., Cuppen, E., Buttner, R., Caldas, C., Grimmond, S., Mullighan, C. G., Elemento, O., Rosenquist, R., Schuh, A., & Haferlach, T. (2022). Analytical demands to use whole-genome sequencing in precision oncology. Seminars in Cancer Biology, 84, 16–22. https://doi.org/10.1016/j.semcancer.2021.06.009

Prasad, M., Ladas, E. J., & Barr, R. (2022). Addition of arm anthropometry to body mass index for age, but not serum albumin, improves the accuracy of the nutritional assessment in severely and moderately malnourished children with cancer. Pediatric Blood & Cancer, 69(9). Portico. https://doi.org/10.1002/pbc.29718

Goldman, J. W., Piha-Paul, S. A., Curti, B., Pedersen, K. S., Bauer, T. M., Groenland, S. L., Carvajal, R. D., Chhaya, V., Kirby, G., McGlinchey, K., Hammond, S. A., Streicher, K., Townsley, D. M., Chae, Y. K., Voortman, J., Marabelle, A., & Powderly, J. (2022). Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors. Clinical Cancer Research, 28(17), 3709–3719. https://doi.org/10.1158/1078-0432.ccr-21-3016

Langouo Fontsa, M., Aiello, M. M., Migliori, E., Scartozzi, M., Lambertini, M., Willard-Gallo, K., & Solinas, C. (2022). Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research. Targeted Oncology, 17(5), 497–505. https://doi.org/10.1007/s11523-022-00908-8

Laise, P., Bosker, G., Califano, A., & Alvarez, M. J. (2022). A Patient‐to‐Model‐to‐Patient (PMP) Cancer Drug Discovery Protocol for Identifying and Validating Therapeutic Agents Targeting Tumor Regulatory Architecture. Current Protocols, 2(9). Portico. https://doi.org/10.1002/cpz1.544

Wang, P. H., Washburn, R., Maniar, R., Mu, M., Ringham, O., Kratchmarov, R., Henick, B. S., & Reiner, S. L. (2022). Cutting Edge: Promoting T Cell Factor 1+ T Cell Self-Renewal to Improve Programmed Cell Death Protein 1 Blockade. The Journal of Immunology, 209(4), 660–664. https://doi.org/10.4049/jimmunol.2200317

Rae, W., Sowerby, J. M., Verhoeven, D., Youssef, M., Kotagiri, P., Savinykh, N., Coomber, E. L., Boneparth, A., Chan, A., Gong, C., Jansen, M. H., du Long, R., Santilli, G., Simeoni, I., Stephens, J., Wu, K., Zinicola, M., Allen, H. L., Baxendale, H., … Smith, K. G. C. (2022). Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations. Science Immunology, 7(74). https://doi.org/10.1126/sciimmunol.abn3800

Zhang, H., Lin, X., & Zha, S. (2022). Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging. Biochemical Society Transactions, 50(4), 1169–1177. https://doi.org/10.1042/bst20220366

Moore, E. K., Strazza, M., & Mor, A. (2022). Combination Approaches to Target PD-1 Signaling in Cancer. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.927265

Church, A. J., Corson, L. B., Kao, P.-C., Imamovic-Tuco, A., Reidy, D., Doan, D., Kang, W., Pinto, N., Maese, L., Laetsch, T. W., Kim, A., Colace, S. I., Macy, M. E., Applebaum, M. A., Bagatell, R., Sabnis, A. J., Weiser, D. A., Glade-Bender, J. L., Homans, A. C., … Janeway, K. A. (2022). Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nature Medicine, 28(8), 1581–1589. https://doi.org/10.1038/s41591-022-01856-6

Afungchwi, G. M., Kruger, M., Hesseling, P., van Elsland, S., Ladas, E. J., & Marjerrison, S. (2022). Survey of the use of traditional and complementary medicine among children with cancer at three hospitals in Cameroon. Pediatric Blood & Cancer, 69(8). Portico. https://doi.org/10.1002/pbc.29675

Gong, Y.-Y., Shao, H., Li, Y., Brafford, P., Stine, Z. E., Sun, J., Felsher, D. W., Orange, J. S., Albelda, S. M., & Dang, C. V. (2022). Na+/H+-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells. Cancer Research Communications, 2(8), 842–856. https://doi.org/10.1158/2767-9764.crc-22-0270

Harimoto, T., Hahn, J., Chen, Y.-Y., Im, J., Zhang, J., Hou, N., Li, F., Coker, C., Gray, K., Harr, N., Chowdhury, S., Pu, K., Nimura, C., Arpaia, N., Leong, K. W., & Danino, T. (2022). A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nature Biotechnology, 40(8), 1259–1269. https://doi.org/10.1038/s41587-022-01244-y

Mullangi, S., Aviki, E. M., Chen, Y., Robson, M., & Hershman, D. L. (2022). Factors Associated With Cancer Treatment Delay Among Patients Diagnosed With COVID-19. JAMA Network Open, 5(7), e2224296. https://doi.org/10.1001/jamanetworkopen.2022.24296

Loh, K. P., Sanapala, C., Watson, E. E., Jensen-Battaglia, M., Janelsins, M. C., Klepin, H. D., Schnall, R., Culakova, E., Vertino, P., Susiarjo, M., Lin, P.-J., Mendler, J. H., Liesveld, J. L., Huselton, E. J., Taberner, K., Mohile, S. G., & Mustian, K. (2022). A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms. Blood Advances, 6(13), 3850–3860. https://doi.org/10.1182/bloodadvances.2022007056

Rosa, W. E., Roberts, K. E., Schlak, A. E., Applebaum, A. J., Breitbart, W. S., Kantoff, E. H., Pessin, H., & Lichtenthal, W. G. (2022). The Critical Need for a Meaning-Centered Team-Level Intervention to Address Healthcare Provider Distress Now. International Journal of Environmental Research and Public Health, 19(13), 7801. https://doi.org/10.3390/ijerph19137801

Yu, J. B., Schrag, D., & Robin Yabroff, K. (2022). Health Economics Research in Cancer Treatment: Current Challenges and Future Directions. JNCI Monographs, 2022(59), 51–56. https://doi.org/10.1093/jncimonographs/lgac009

Yu, J. B. (2022). Fostering Transdisciplinary Collaborations in Cancer Health Economics Research. JNCI Monographs, 2022(59), 85–88. https://doi.org/10.1093/jncimonographs/lgac001

Matsuo, K., Klar, M., Youssefzadeh, A. C., Mandelbaum, R. S., Roman, L. D., Ouzounian, J. G., & Wright, J. D. (2022). Assessment of Severe Maternal Morbidity and Mortality in Pregnancies Complicated by Cancer in the US. JAMA Oncology, 8(8), 1213. https://doi.org/10.1001/jamaoncol.2022.1795

Lopci, E., Hicks, R. J., Dimitrakopoulou-Strauss, A., Dercle, L., Iravani, A., Seban, R. D., Sachpekidis, C., Humbert, O., Gheysens, O., Glaudemans, A. W. J. M., Weber, W., Wahl, R. L., Scott, A. M., Pandit-Taskar, N., & Aide, N. (2022). Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0. European Journal of Nuclear Medicine and Molecular Imaging, 49(7), 2323–2341. https://doi.org/10.1007/s00259-022-05780-2

Guo, Z., Buonanno, M., Harken, A., Zhou, G., & Hei, T. K. (2022). Mitochondrial Damage Response and Fate of Normal Cells Exposed to FLASH Irradiation with Protons. Radiation Research, 197(6). https://doi.org/10.1667/rade-21-00181.1

Huan, T., Nguyen, S., Colicino, E., Ochoa‐Rosales, C., Hill, W. D., Brody, J. A., Soerensen, M., Zhang, Y., Baldassari, A., Elhadad, M. A., Toshiko, T., Zheng, Y., Domingo‐Relloso, A., Lee, D. H., Ma, J., Yao, C., Liu, C., Hwang, S., Joehanes, R., … Levy, D. (2022). Integrative analysis of clinical and epigenetic biomarkers of mortality. Aging Cell, 21(6). Portico. https://doi.org/10.1111/acel.13608

Rubinstein, S. M., Bhutani, D., Lynch, R. C., Hsu, C.-Y., Shyr, Y., Advani, S., Mesa, R. A., Mishra, S., Mundt, D. P., Shah, D. P., Sica, R. A., Stockerl-Goldstein, K. E., Stratton, C., Weiss, M., Beeghly-Fadiel, A., Accordino, M., Assouline, S. E., Awosika, J., … Bakouny, Z. (2022). Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19. Blood Cancer Discovery, 3(3), 181–193. https://doi.org/10.1158/2643-3230.bcd-22-0013